Pillstats
Rx only · Solution · Nasal

Flunisolide

Flunisolide

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCR01AD04
RxCUI (US)25120
US makers3 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.559$1.12$1.68$2.23Dec 2025Apr 2026Jul 2026
$1.943
Latest avg · Jul 22, 2026
+4%
Since Dec 17, 2025
3
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.4K2.8K4.2K5.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.6K
Rx · 2026 Q1
73K
Units dispensed
-46%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bausch & Lomb Incorporatedunknown1SUPPLYING
Ingenus Pharmaceuticals, LLCunknown1SUPPLYING
Oceanside Pharmaceuticalsunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 30, 2022
    RECALLRecall (Class II): Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando,…

    Out of specification for related substances (impurities). — Recalling firm: Ingenus Pharmaceuticals Llc — Nationwide within the United States